Survey about impact of COVID-19 symptoms on daily life and labor productivity

Survey about impact of COVID-19 symptoms on daily life and labor productivity - Survey about impact of COVID-19 symptoms on daily life and labor productivity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049446

Enrollment

2000

Registered

2022-11-08

Start date

2022-11-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Those who were diagnosed with COVID-19 during April to August 2022 and had symptoms 2)Those who were treated at home or accommodation

Exclusion criteria

Exclusion criteria: Those who do not consent to this survey

Design outcomes

Primary

Measure	Time frame
Outcomes for COVID-19 survey items 1)Symptoms, severity of symptoms, duration of symptoms 2)Impact on social and daily life by symptoms 3)Time until work/study/housework resuming 4)Importance of early COVID-19 symptoms disappearance 5)Importance of prevention of the transmission of SARS-CoV-2 to contacts 6)Importance of earlier test negative for SARS-CoV-2 7)Anxiety/fear with risk of household transmission, death, sequelae 8)Satisfaction with the treatment	—

Measure

Time frame

Outcomes for COVID-19 survey items 1)Symptoms, severity of symptoms, duration of symptoms 2)Impact on social and daily life by symptoms 3)Time until work/study/housework resuming 4)Importance of early COVID-19 symptoms disappearance 5)Importance of prevention of the transmission of SARS-CoV-2 to contacts 6)Importance of earlier test negative for SARS-CoV-2 7)Anxiety/fear with risk of household transmission, death, sequelae 8)Satisfaction with the treatment

—

Secondary

Measure	Time frame
Outcomes for post-acute COVID-19 syndrome survey items 1)Symptoms, severity of symptoms, duration of symptoms 2)Impact on social and daily life by symptoms 3)Time until work/study/housework can be done 4)Impact on work/school/housework productivity 5)Changes in the work environment (changes in work content, leave of absence, retirement, job change) 6)Anxiety/fear with post-acute COVID-19 syndrome	—

Countries

Japan

Contacts

Public ContactShintaro Tanaka

Shionogi & Co., Ltd. Medical Affairs Department

shintarou.tanaka@shionogi.co.jp080-2409-3174

Outcome results